Lipoprotein(a) Levels in Thyroid Disorders

1. Berg K. A new serum type system in man: the Lipoprotein(a) system. Acta Pathol Microbiol Scand. 1963;59:369-382.10.1111/j.1699-0463.1963.tb01808.x14064818Search in Google Scholar

2. Watts GF, Keamey EM, Taub NA, Slavin BM. Lipoprotein(a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia. Jf Clin Patho. 1993;46:267-270.10.1136/jcp.46.3.2675011848463422Search in Google Scholar

3. Zhu X, Cheng SY. New insights into regulation of lipid metabolism by thyroid hormone. Current Opinion in Endocrinology, Diabetes and Obesity. 2010;17(5):408-413.10.1097/MED.0b013e32833d6d46345777720644471Search in Google Scholar

4. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109III:15-19.10.1161/01.CIR.0000131513.33892.5b15198961Search in Google Scholar

5. Discepolo W, Wun T, Berglund L. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb. 2006;35:314-21.10.1159/00009322416877880Search in Google Scholar

6. Koschinsky ML. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovasc Hematol Disord Drug Targets. 2006;6:267-78.Search in Google Scholar

7. Anuurad E, Boffa MB, Koschinsky ML, Berglund L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med. 2006;26:751-72.10.1016/j.cll.2006.07.00217110238Search in Google Scholar

8. Zorio E, Falco C, Arnau MA, et al. Lipoprotein(a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Haematologica. 2006;91:562-5.Search in Google Scholar

9. Santi A, Duarte M, Moresco RN, et al. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clinical Chemistry and Laboratory Medicine. 2010;48(11):1635-1639.10.1515/CCLM.2010.30920704527Search in Google Scholar

10. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491-6.10.1210/jc.2006-171817090642Search in Google Scholar

11. Peppa M, Betsi G, Dimitriadis G. Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease. J Lipids. 2011; 2011: 575840. Published online 2011 July 18. doi: 10.1155/2011/575840.Search in Google Scholar

12. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a populationbased study. The HUNT Study. Eur J Endocrinol. 2007;156:181-6.Search in Google Scholar

13. Enkhmaa B, Anuurad E, Zhang W, Tran T, Berglund L. Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk. Metab Syndr Relat Disord. 2011;9(6):411-8.10.1089/met.2011.0026322506121749171Search in Google Scholar

14. Bruckert E, Thomas D. Les hypercholesterolemies. John Libbey Eurotext, London, 1997, 28-53.Search in Google Scholar

15. Takagi H. Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials. Int J Cardiol. 2012;154(2):183-6.10.1016/j.ijcard.2011.09.06021996415Search in Google Scholar

16. Dumitrescu L, Glenn K, Brown-Gentry K et al. Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey. 2011 PLoS ONE 6 (1): e16604.10.1371/journal.pone.0016604Search in Google Scholar

17. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 2010;31(23):2844-53.10.1093/eurheartj/ehq386Search in Google Scholar

18. Dubé JB, Boffa MB, Hegele RA, Koschinsky ML. Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol. 2012;23(2):133-40.10.1097/MOL.0b013e32835111d8Search in Google Scholar

19. George RM, Torelli J. Beyond cholesterol: 7 life-saving heart disease tests that your doctor may not give you. New York: St. Martin's Griffin. 2005. p.91.Search in Google Scholar

20. De Bruin TW, van Barlingen H, van Linde-Sibenius TM, et al. Lipoprotein(a) and Apolipoprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J Clin Endocrinol Metab. 1993;76:121-126.Search in Google Scholar

21. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J. 2011;5:76-84.10.2174/1874192401105010076Search in Google Scholar

22. Boda J, Paragh G, Szabo J, et al. Lipoprotein(a) studies in thyroid diseases. Orv Hetil. 1997;138:2307.Search in Google Scholar

23. Lotz H, Salabe GB. Lipoprotein(a) increase associated with thyroid autoimmunity. Eur J Endocrinol. 1997;136(1):87-91.10.1530/eje.0.1360087Search in Google Scholar

24. Bairaktari ET, Tselepis AD, Millionis HJ, Elisaf MS. Lipoprotein(a) levels, apoLipoprotein(a) phenotypes and thyroid autoimmunity. Eur J Endocrinol. 1999;140:474-6.10.1530/eje.0.1400474Search in Google Scholar

25. Tagami T, Tamanaha T, Shimazu S, et al. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocrine Journal. 2010;57(3):253-258.10.1507/endocrj.K09E-315Search in Google Scholar

26. Toruner F, Altinova AE, Karakoc A, et al. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25:430-7.10.1007/s12325-008-0053-7Search in Google Scholar

27. Dullaart RPF, van Doormaal JJ, Hoogenberg K, Sluiter WJ. Triiodothyronine rapidly lowers plasma Lipoprotein(a) in hypothyroid subjects. Netherlands Journal of Medicine. 1995;46(4):179-184.10.1016/0300-2977(94)00116-QSearch in Google Scholar

28. Lee WY, Suh JY, Rhee EJ, et al. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status. Arch Med Res. 2004;35:540-5.10.1016/j.arcmed.2004.08.00315631881Search in Google Scholar

29. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Relationship between Lipoprotein(a) and thyroid function status in the general population. Arch Med Res. 2007;38:905-6.10.1016/j.arcmed.2007.06.00317923276Search in Google Scholar

30. Riche DM, East HE, Priest HM. Practical management of dyslipidemia with elevated Lipoprotein(a). J Am Pharm Assoc. 2008;48(6):803-7.10.1331/JAPhA.2008.0710919019811Search in Google Scholar

31. Neves C, Alves M, Medina JL, Delgado JL. Review Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol. 2008; 27(10):1211-36.Search in Google Scholar

32. Teixeira P, Reuters VS, Ferreira MM, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Translational Research. 2008;151(4):224-231. 10.1016/j.trsl.2007.12.00618355770Search in Google Scholar